239 related articles for article (PubMed ID: 30849393)
21. The role of RNA editing by ADAR1 in prevention of innate immune sensing of self-RNA.
Heraud-Farlow JE; Walkley CR
J Mol Med (Berl); 2016 Oct; 94(10):1095-1102. PubMed ID: 27044320
[TBL] [Abstract][Full Text] [Related]
22. RNA-Editing Enzyme ADAR1 p150 Isoform Is Critical for Germinal Center B Cell Response.
Li Y; Ruan GX; Chen W; Huang H; Zhang R; Wang J; Li Y; Xu S; Ou X
J Immunol; 2022 Sep; 209(6):1071-1082. PubMed ID: 35977796
[TBL] [Abstract][Full Text] [Related]
23. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
Fritzell K; Xu LD; Lagergren J; Öhman M
Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
[TBL] [Abstract][Full Text] [Related]
24. Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells.
Gannon HS; Zou T; Kiessling MK; Gao GF; Cai D; Choi PS; Ivan AP; Buchumenski I; Berger AC; Goldstein JT; Cherniack AD; Vazquez F; Tsherniak A; Levanon EY; Hahn WC; Meyerson M
Nat Commun; 2018 Dec; 9(1):5450. PubMed ID: 30575730
[TBL] [Abstract][Full Text] [Related]
25. Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses.
Samuel CE
J Biol Chem; 2019 Feb; 294(5):1710-1720. PubMed ID: 30710018
[TBL] [Abstract][Full Text] [Related]
26. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
[TBL] [Abstract][Full Text] [Related]
27. To "Z" or not to "Z": Z-RNA, self-recognition, and the MDA5 helicase.
Herbert A
PLoS Genet; 2021 May; 17(5):e1009513. PubMed ID: 33983939
[TBL] [Abstract][Full Text] [Related]
28. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
Liu Y; Wolff KC; Jacobs BL; Samuel CE
Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
[TBL] [Abstract][Full Text] [Related]
29. RNA editing underlies genetic risk of common inflammatory diseases.
Li Q; Gloudemans MJ; Geisinger JM; Fan B; Aguet F; Sun T; Ramaswami G; Li YI; Ma JB; Pritchard JK; Montgomery SB; Li JB
Nature; 2022 Aug; 608(7923):569-577. PubMed ID: 35922514
[TBL] [Abstract][Full Text] [Related]
30. Cis- and trans-regulations of pre-mRNA splicing by RNA editing enzymes influence cancer development.
Tang SJ; Shen H; An O; Hong H; Li J; Song Y; Han J; Tay DJT; Ng VHE; Bellido Molias F; Leong KW; Pitcheshwar P; Yang H; Chen L
Nat Commun; 2020 Feb; 11(1):799. PubMed ID: 32034135
[TBL] [Abstract][Full Text] [Related]
31. Deciphering the principles of the RNA editing code via large-scale systematic probing.
Uzonyi A; Nir R; Shliefer O; Stern-Ginossar N; Antebi Y; Stelzer Y; Levanon EY; Schwartz S
Mol Cell; 2021 Jun; 81(11):2374-2387.e3. PubMed ID: 33905683
[TBL] [Abstract][Full Text] [Related]
32. ADAR1 and its implications in cancer development and treatment.
Baker AR; Slack FJ
Trends Genet; 2022 Aug; 38(8):821-830. PubMed ID: 35459560
[TBL] [Abstract][Full Text] [Related]
33. The human but not the Xenopus RNA-editing enzyme ADAR1 has an atypical nuclear localization signal and displays the characteristics of a shuttling protein.
Eckmann CR; Neunteufl A; Pfaffstetter L; Jantsch MF
Mol Biol Cell; 2001 Jul; 12(7):1911-24. PubMed ID: 11451992
[TBL] [Abstract][Full Text] [Related]
34. Extensive editing of cellular and viral double-stranded RNA structures accounts for innate immunity suppression and the proviral activity of ADAR1p150.
Pfaller CK; Donohue RC; Nersisyan S; Brodsky L; Cattaneo R
PLoS Biol; 2018 Nov; 16(11):e2006577. PubMed ID: 30496178
[TBL] [Abstract][Full Text] [Related]
35. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
Ganem NS; Ben-Asher N; Lamm AT
Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
[TBL] [Abstract][Full Text] [Related]
36. ADAR1 Prevents Autoinflammatory Processes in the Heart Mediated by IRF7.
Garcia-Gonzalez C; Dieterich C; Maroli G; Wiesnet M; Wietelmann A; Li X; Yuan X; Graumann J; Stellos K; Kubin T; Schneider A; Braun T
Circ Res; 2022 Sep; 131(7):580-597. PubMed ID: 36000401
[TBL] [Abstract][Full Text] [Related]
37. ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing.
Nie Y; Ding L; Kao PN; Braun R; Yang JH
Mol Cell Biol; 2005 Aug; 25(16):6956-63. PubMed ID: 16055709
[TBL] [Abstract][Full Text] [Related]
38. RNA Editing by ADAR Adenosine Deaminases: From Molecular Plasticity of Neural Proteins to the Mechanisms of Human Cancer.
Goncharov AO; Kliuchnikova AA; Nasaev SS; Moshkovskii SA
Biochemistry (Mosc); 2019 Aug; 84(8):896-904. PubMed ID: 31522671
[TBL] [Abstract][Full Text] [Related]
39. ADAR1 Regulates Early T Cell Development via MDA5-Dependent and -Independent Pathways.
Vongpipatana T; Nakahama T; Shibuya T; Kato Y; Kawahara Y
J Immunol; 2020 Apr; 204(8):2156-2168. PubMed ID: 32169840
[TBL] [Abstract][Full Text] [Related]
40. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains.
Chen CX; Cho DS; Wang Q; Lai F; Carter KC; Nishikura K
RNA; 2000 May; 6(5):755-67. PubMed ID: 10836796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
